Ledger.Open graph →
SEC Form D · filed December 19, 2025

Lexaria Bioscience Corp

Offering
$3.5M
Sold
$3.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
KELOWNA, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Bal E. Bhullar · Kelowna, British Columbia, CanadaDirectorWilliam E. Mckechnie · Kelowna, British Columbia, CanadaDirectorBal E. Bhullar · Kelowna, British Columbia, CanadaDirectorWilliam E. Mckechnie · Kelowna, British Columbia, CanadaDirectorNicholas Baxter · Kelowna, British Columbia, CanadaDirectorMichael Shankman · Kelowna, British Columbia, CanadaExecAlbert E. Reese · Kelowna, British Columbia, CanadaDirectorChristopher Bunka · Kelowna, British Columbia, CanadaDirectorJohn Docherty · Kelowna, British Columbia, CanadaExec · DirectorRichard Christopher · Kelowna, British Columbia, CanadaExec · DirectorEnTrust Partners Offshore LLC · New York, NYDirectorDavid H. Schwartz · Great Neck, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗